Paper
0
Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study
Authors
Meletios Dimopoulos,Peter Voorhees
Fredrik Schjesvold,Yaël Cohen,Vânia Hungria,Irwindeep Sandhu,Jindriska Lindsay,Ross Baker,Kenshi Suzuki,Hiroshi Kosugi,Mark‐David Levin,Meral Beksac,Keith Stockerl‐Goldstein,Albert Oriol,Gábor Mikala,Gonzalo Garate,Koen Theunissen,Ivan Špıčka,Anne Mylin,Sara Galimberti,Katarina Uttervall,Bartosz Pula,Eva Medvedova,Andrew Cowan,Philippe Moreau,María‐Victoria Mateos,Hartmut Goldschmidt,Tahamtan Ahmadi,Linlin Sha,Els Rousseau,Liang Li,Robyn Dennis,Robin Carson
+31 authors
,S. RajkumarJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave